Bernstein downgraded Smith & Nephew from Outperform to Mkt Perform and set a new price target of $37.50
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/15/2025 | Outperform → Sector Perform | RBC Capital Mkts | |
| 10/14/2025 | $37.50 | Outperform → Mkt Perform | Bernstein |
| 4/25/2025 | Buy → Hold | HSBC Securities | |
| 3/12/2025 | Buy → Neutral | UBS | |
| 11/6/2024 | Buy → Hold | Berenberg | |
| 11/1/2024 | Buy → Hold | Deutsche Bank | |
| 7/24/2024 | Buy | Deutsche Bank | |
| 6/5/2024 | Neutral → Buy | UBS |
3 - SMITH & NEPHEW PLC (0000845982) (Reporting)
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces compelling new randomized control trial (RCT) data confirming significant outcome improvements for patients with partial-thickness rotator cuff tears treated with the REGENETEN Bioinductive Implant in isolation.1,* Compared with a traditional suture anchor repair, early recovery time was halved1 for patients returning to daily activities such as: Driving: 2.3 vs 5.1 weeks (p<0.001)1,**Office work: 1.7 vs 3.6 weeks (p=0.009)1,**Moderate-intensity household chores: 3.8 vs 8.4 weeks (p<
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed by a portfolio of strong scientific data and clinical evidence. ALLEVYN COMPLETE CARE Dressing has a unique five-layer construction with distinct mode of action technologies targeted towards both wound management and pressure injury prevention. Minimising leakage1-4 and disruption by fewer dressing changes5-7, and protecting vulnerable skin8-10 are essential to achieving this goal. Global estimates suggest that up to one in 50 adults are affected by chronic wounds in their lifetime, facing
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature handheld robotics and digital solutions for hip, knee and shoulder in addition to innovative trauma and extremities products during the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in New Orleans this week. Some of the company's latest Orthopaedics advancements and highlighted technologies include:Handheld Robotics: Optimizing and Personalizing Surgery As the leader in handheld robotics, the CORI◊ Surgical System delivers a digital surgery ecosystem–spanning solutions from advanced pre-operative planning and a connected post-operative data management solution. The entir
RBC Capital Mkts downgraded Smith & Nephew from Outperform to Sector Perform
Bernstein downgraded Smith & Nephew from Outperform to Mkt Perform and set a new price target of $37.50
HSBC Securities downgraded Smith & Nephew from Buy to Hold
6-K - SMITH & NEPHEW PLC (0000845982) (Filer)
6-K - SMITH & NEPHEW PLC (0000845982) (Filer)
6-K - SMITH & NEPHEW PLC (0000845982) (Filer)
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value. Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy
STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence, Inc., a leading provider of vertically integrated contract manufacturing solutions to the MedTech and Pharma markets, is pleased to announce the appointment of Bob White to its Board of Directors. Mr. White brings over 25 years of business leadership experience and a proven track record in operational excellence, technological innovation, and strategic growth to Cadence. Mr. White has demonstrated exceptional skills in managing global locations, having held senior positions at Medtronic, GE Healthcare, and IBM. He recent
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder repair business with the most comprehensive suite of technologies available for rotator cuff repair (RCR). Integrity Orthopaedics is a US‑based, early‑stage commercial developer of Tendon Seam™, an innovative and disruptive biomechanical RCR system designed to significantly reduce re‑tear rates and improve patient outcomes versus the current standard of care. Tendon Seam™ allows for a novel repair stitch configuration with multiple points of fixation. Its patented microanchors, continuous sutu
New York, United States, March 03, 2025 (GLOBE NEWSWIRE) -- The global demand for wound care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Download Free Sample Report PDF @ https://straitsresearc
New York, United States, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The global demand for Wound Care products is increasing as the number of patients with chronic and acute wounds rises. Market leaders continually focus on introducing innovative wound care products to meet unmet demand. As a result, more people are using conventional, bioactive, and other wound care products. In addition, governments in developing nations and other for-profit and non-profit organizations are increasingly focusing on various awareness campaigns to educate the public about innovative product offerings and therapeutic options for chronic and advanced wounds. Get a Free Sample Copy of This Report https://stra
SC 13D - SMITH & NEPHEW PLC (0000845982) (Subject)
SC 13G/A - SMITH & NEPHEW PLC (0000845982) (Subject)